[1]潘文,王贵霞,王晓萍.多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用[J].西部中医药,2012,25(12):121-123.
 PAN Wen,WANG Gui-xia,WANG Xiao-ping.Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(12):121-123.
点击复制

多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
25
期数:
2012年12期
页码:
121-123
栏目:
出版日期:
2012-12-15

文章信息/Info

Title:
Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine
文章编号:
1004-6852(2012)12-0121-03
作者:
潘文1王贵霞2王晓萍3
1 甘肃省中医药研究院,甘肃 兰州 730050;2 甘肃中医学院;3 甘肃省中医院
Author(s):
PAN Wen1 WANG Gui-xia2 WANG Xiao-ping3
1 Gansu Province Academy of Chinese Medicine, Lanzhou 730050, China; 2 Gansu University of Traditional Chinese Medicine; 3 Gansu Province Hospital of Traditional Chinese Medicine
关键词:
多囊卵巢综合征胰岛素抵抗病因病机中药干预作用
Keywords:
polycystic ovary syndrome insulin resistance causes and pathogenesis TCM intervention
分类号:
R711.75
文献标志码:
A
摘要:
通过分析近年来的相关文献,对多囊卵巢综合征伴胰岛素抵抗的发病机制和中药对其胰岛素抵抗的干预作用进行了分析、阐述,以期为今后的研究提供参考。
Abstract:
Pathogenesis of polycystic ovary syndrome (PCOS) complicated with insulin resistance and the intervention with TCM on insulin resistance were illustrated through analyzing associated literature in recent years in order to provide reference for further study.

参考文献/References:

[1] Dunaif A.Insulin resistance and the polycystic ovary syndrome:Mechanism and implications for pathogenesis[J].Endocrine Rev,1997,18(6):774-800. [2] 任文凯,马其江,李淑玲.多囊卵巢综合征病因与治疗研究进展[J].山东中医药大学学报,2011,35(1):89-92. [3] Corbould A.Effects of androgens on insulin action in women:is androgen excess a component of female metabolic syndrome[J].Diabetes Metab Res Rev,2008,24(7):520-532. [4] Wu XK,Zhou SY,Liu JX,et al.Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome[J].Fertil Steril,2003,80(4):954-965. [5] Wu XK,Sallinen K,AnttilaL,et al.Expression of insulin 2 receptor substrate-1 and-2 in ovaries from women with insulin resistance and from controls[J].Fertility and Sterility,2000,74(3):564-572. [6] Anil Kumar KL,Marita AR.Troglitazone prevents and reverses dexamethasone induced insulin resistanceon glycogens synthesis in 3 T3 adipocytes[J].Br J Pharmacol,2009,130(2):351-358. [7] Padmanabhan V.Polycystic ovary syndrome-"A riddle wrapped in a mystery inside an enigma"[J].J Clin Endocrinol Metab,2009,94(6):1883-1885. [8] Barba M,S chunemann HJ,Sperati F,et al.The effects of metformin on endogenous androgens and SHBG in women:A systematic review and meta-analysis[J].Clin Endocrinol,2008,70(5):661-670. [9] Asagami T,Holmes TH,Reaven G.Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation[J].M etabolism,2008,57(10):1355-1360. [10]Karimzadeh MA,Javedani M.An assessment of lifestyle modification versus medical treatment with clomiphene citrate,etformin and clomiphene citratemet formin in patients with polycystic ovary syndrome[J].Fertil Steril,2010,94(1):216-220. [11]黄健康,李启富.胰岛素抵抗与多囊卵巢综合征[J].医学综述,2005,11(5):389-391. [12]张静,刘旗.瘦素与肿瘤坏死因子 琢 基因多态性与多囊卵巢综合征发病相关性研究[J].中国卫生检验杂志,2010,20(12):3272-3274. [13]李楠,丛晶,吴效科,等.多囊卵巢综合征易感基因研究进展[J].医学研究杂志,2010,39(1):122-124. [14]杨艳,乔杰,李美芝.白细胞介素 18、白细胞介素1β与多囊卵巢综合征发病的相关性研究[J].中国实用妇科与产科杂志,2008,24(1):38-40. [15] Ardawi MS,Ronzi AA.Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome[J].Fertil Steril,2005,83(6):705-708. [16]许良智,单丹.多囊卵巢综合征———一种代谢障碍性全身性疾病在卵巢的表现[J].中华妇幼临床医学杂志,2011,7(5):321-325. [17]程丽平,夏丽,饶惠玲,等.抗苗勒氏管激素、瘦素与多囊卵巢综合征的相关性[J].中国妇幼保健,2008,23(29):4106-4109. [18]王智民,李文雅.多囊卵巢综合征患者糖化血红蛋白变化分析[J].内蒙古中医药,2011,30(21):101-102. [19]谭庆玲.青春期多囊卵巢综合征患者内分泌、代谢紊乱特征分析[J].中国医药导报,2011,8(36):42-44. [20]杨冬梓,陈晓莉.青春期多囊卵巢综合征的诊治进展[J].中国实用妇科与产科杂志,2010,26(7):549-553. [21]李晓林,马慧敏,张丽丽,等.多囊卵巢综合征胰岛素抵抗与卵巢局部 IGF-I 系统的相关性研究[J].中国妇产科临床杂志,2010,11(5):331-334. [22]胡燕宁.青少年多囊卵巢综合征与其父母代谢综合征的相关性研究[J].现代中西医结合杂志,2008,17(3):335-337. [23]张翠莲,张少娣,李杭生,等.多囊卵巢综合征患者胰岛素抵抗与肥胖的研究和分析[J].中华实用诊断与治疗杂志,2008,22(11):807-809. [24]Tan BK,Adya R,Farhatullah S,et al.Omentin-1 a novel adipokine,isdecreasedinoverweightinsulin-resistant women with polycystic ovary syndrome:exvivo and in vivo regulation of omentin-1 by insulin and glucose[J].Diabetes,2008,57(4):801-808. [25]杨在春.多囊卵巢综合征患者代谢异常及处理进展[J].临床合理用药杂志,2012,5(1C):153-154. [26]孙维峰,梁静,张娴娴,等.补肾活血化痰法治疗多囊卵巢综合征胰岛素抵抗的临床研究[J].中华中医药学刊,2011,29(9):2018-2020. [27]王岩,陈莹,王昕.苍附导痰汤对肥胖型多囊卵巢综合征患者脂联素、瘦素及胰岛素抵抗的影响[J].中华中医药学刊,2011,29(11):2556-2558. [28]徐江红,佟杰,杨洪波.耳针与中药并用对多囊卵巢综合征胰岛素抵抗的影响[J].世界中医药,2011,6(1):61-62. [29]赵秋生,谭秀芬,王南苏.桂枝茯苓丸对多囊卵巢综合征大鼠胰岛素抵抗及脂联素的影响[J].新中医,2012,44(1):116-117. [30]张宁.中药对多囊卵巢综合征痰湿证性激素及性激素结合球蛋白表达的干预性研究[J].贵阳中医学院学报,2011,33(5):43-45.

相似文献/References:

[1]梁荣伟,刘新雄,李学余,等.穴位针刺加封闭联合辅助生殖技术对 PCOS 不孕患者激素水平的影响*[J].西部中医药,2013,26(02):98.
 LIANG Rongwei,LIU Xinxiong,LI Xueyu,et al.The Effects of Acupoint Block, Needling and Assisted Reproductive Technique on the Level of Hormone in Infertile Patients with PCOS[J].Western Journal of Traditional Chinese Medicine,2013,26(12):98.
[2]汪雪晴,曾敬.补肾调经方联合达英-35治疗多囊卵巢综合征疗效观察[J].西部中医药,2012,25(11):78.
 WANG Xue-qing,ZENG Jing.Clinical Observation on BuShen TiaoJingFang Combined with Ethinylestradiol and Cyproterone Acetate Tablets for Polycystic Ovary Syndrome[J].Western Journal of Traditional Chinese Medicine,2012,25(12):78.
[3]王针织,周丽虹,俞超芹△,等.补肾活血祛痰方治疗肥胖型与非肥胖型多囊卵巢综合征的疗效研究*[J].西部中医药,2014,27(04):1.
 WANG Zhenzhi,ZHOU Lihong,YU Chaoqin,et al.Study on Clinical Effects of Kidney-invigorating Blood-activating Phlegm-eliminating Prescription in Treating Polycystic Ovary Syndrome of Obesity Type and Non-obesity Type[J].Western Journal of Traditional Chinese Medicine,2014,27(12):1.
[4]苏庆华,张建伟△.多囊卵巢综合征中医证型与内分泌代谢指标相关性研究[J].西部中医药,2014,27(04):143.
 SU Qinghua,ZHANG Jianwei.Research on the Relativity between the Indexes of Metabolic Endocrinology and TCM Patterns of PCOS[J].Western Journal of Traditional Chinese Medicine,2014,27(12):143.
[5]康开彪,牛崇信,指导:潘文.潘文教授对多囊卵巢综合征中医病因的认识[J].西部中医药,2014,27(08):22.
[6]周雨聪,指导:刘召.红灵五黄汤治疗2型糖尿病90例[J].西部中医药,2015,28(04):99.
[7]杨维杰,康学东△,朱瑾,等.解毒化浊方对胰岛素抵抗大鼠GLUT4 mRNA表达的影响[J].西部中医药,2015,28(07):8.
[8]康学东,张瀚文.病证结合探讨2型糖尿病胰岛素抵抗[J].西部中医药,2015,28(11):112.
[9]安小平,崔庆荣,康学东.苦瓜胶囊治疗2型糖尿病胰岛素抵抗的临床观察[J].西部中医药,2017,30(03):1.
 AN Xiaoping,CUI Qingrong,KANG Xuedong.Clinical Observation on Function of KuGua Capsule for Improving Insulin Resistance in Patients with Type Two Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2017,30(12):1.
[10]雍志强,潘文△,张瑞瑞,等.补肾化瘀方对PCOS血清IKK表达的临床影响[J].西部中医药,2017,30(04):80.
 YONG Zhiqiang,PAN Wen,ZHANG Ruirui,et al.The Effects of BuShen HuaYu Prescription on Serum IKK Expression of PCOS Patients[J].Western Journal of Traditional Chinese Medicine,2017,30(12):80.
[11]张翌蕾,潘文△,汪永娟,等.补肾化瘀方对PCOS大鼠血清激素水平的影响[J].西部中医药,2016,29(02):5.
 ZHANG Yilei,PAN Wen,WANG Yongjuan,et al.The Influence of BuShen HuaYu Prescription on the Levels of Hormone of PCOS Rats[J].Western Journal of Traditional Chinese Medicine,2016,29(12):5.

备注/Memo

备注/Memo:
收稿日期:2012-09-05 作者简介:潘文(1963—),女,硕士研究生导师,主任医师,中华中医药学会编辑出版分会副主任委员,中华中医药学会科普分会副主任委员,中华中医药学会文化分会常务理事,甘肃省领军人才,甘肃省“555”创新人才,甘肃省卫生厅中青年学术技术带头人,甘肃省中医药学会副会长,甘肃省中医药学会文化专业委员会副主任委员兼秘书长,甘肃省中医药学会仲景学说研究会副主任委员,甘肃省科技期刊专家。研究方向:不孕症的中西医结合治疗。
更新日期/Last Update: 1900-01-01